Skip to content
About Us
History
Leadership
Scientific Advisory Board
Collaboration and Partnership
Locations
Science & Technology
Small Molecules
NMS ADC Platform
Pipeline
Small Molecules
Marketed
Encorafenib (BRAF)
Entrectinib (TRK, ROS)
NAD+ Binding Family: PARP
Itareparib (NMS-293, PARP1)
Atamparib (PARP7)
Early Pipeline Projects
Kinases
Onvansertib (PLK1)
NMS-812 (PERK/ GCN2)
Early Pipeline Projects
ADC Platform
Duocarmycin
HER3 Novel Duocarmycin
Anthracycline
Nectin-4 Next-gen Anthracycline
Partnered
Peptide Drug Conjugates (PDCs)
News/Events & Publications
News
Events
Publications
Careers
Contact Us
About Us
History
Leadership
Scientific Advisory Board
Collaboration and Partnership
Locations
Science & Technology
Small Molecules
NMS ADC Platform
Pipeline
Small Molecules
Marketed
Encorafenib (BRAF)
Entrectinib (TRK, ROS)
NAD+ Binding Family: PARP
Itareparib (NMS-293, PARP1)
Atamparib (PARP7)
Early Pipeline Projects
Kinases
Onvansertib (PLK1)
NMS-812 (PERK/ GCN2)
Early Pipeline Projects
ADC Platform
Duocarmycin
HER3 Novel Duocarmycin
Anthracycline
Nectin-4 Next-gen Anthracycline
Partnered
Peptide Drug Conjugates (PDCs)
News/Events & Publications
News
Events
Publications
Careers
Contact Us
Search
17th Discovery on target 2019
Home
/
17th Discovery on target 2019
September 16-19
Boston, MA
17
th
Discovery on target 2019
27th Protein Structure Determination in Industry Meeting
ESMO 2019
Share this page
Facebook
Twitter
LinkedIn
Email
svg.e-font-icon-svg {display:none!important} .elementor-button-icon {display:none!important} .show-more, .show-more2 {display:none!important} img.pf-large-image.pf-primary-img.flex-width.pf-size-full.blockImage { display: none!important; }